- Home
- BSX vs BME Comparison
BSX vs BME Comparison
Compare BSX & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BSX | BME |
|---|---|---|
| Founded | 1979 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.8B | 534.8M |
| IPO Year | 1992 | N/A |
Fundamental Metrics
Financial Performance| Metric | BSX | BME |
|---|---|---|
| Price | $96.31 | $41.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $125.88 | N/A |
| AVG Volume (30 Days) | ★ 9.5M | 34.0K |
| Earning Date | 02-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.26% |
| EPS Growth | ★ 54.68 | N/A |
| EPS | ★ 1.87 | 1.44 |
| Revenue | ★ $19,349,000,000.00 | N/A |
| Revenue This Year | $21.05 | N/A |
| Revenue Next Year | $11.44 | N/A |
| P/E Ratio | $51.37 | ★ $28.37 |
| Revenue Growth | ★ 21.61 | N/A |
| 52 Week Low | $85.98 | $35.53 |
| 52 Week High | $109.50 | $43.20 |
Technical Indicators
Market Signals| Indicator | BSX | BME |
|---|---|---|
| Relative Strength Index (RSI) | 49.66 | 58.05 |
| Support Level | $95.55 | $40.41 |
| Resistance Level | $96.48 | $41.46 |
| Average True Range (ATR) | 1.65 | 0.38 |
| MACD | 0.43 | -0.01 |
| Stochastic Oscillator | 87.08 | 78.79 |
Price Performance
Historical ComparisonAbout BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.